Short and long term effects of a two-week transcutaneous vagus nerve stimulation in hyperadrenergic postural orthostatic tachycardia syndrome: a proof-of-concept trial
European Journal of Internal Medicine · 2026
DOI: 10.1016/j.ejim.2025.106529 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Internal Medicine, 2026. Verfasst von Dana Shiffer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 42 - Pieve Emanuele, Milan, Italy; Humanitas Clinical and Research…. Hauptthemen laut MEDLINE: Postural Orthostatic Tachycardia Syndrome, Vagus Nerve Stimulation, Transcutaneous Electric Nerve Stimulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND AND AIMS: Hyperadrenergic POTS (Hyper-POTS) is characterized by excessive central sympathetic activity and impaired cardiovagal modulation. A single transcutaneous vagus nerve stimulation (tVNS) rebalanced cardiovascular autonomic control in previous studies. Repetitive tVNS may similarly restore autonomic balance and improve symptoms in Hyper-POTS. METHODS: Twenty-two Hyper-POTS were studied at baseline (Pre-tVNS), after 14 days of tVNS (tVNS), and within 24 months post-discontinuation (Post-tVNS). The modified Vanderbilt Orthostatic Symptoms Score (mVOSS) quantified symptoms. ECG, arterial pressure, respiratory activity, and muscle sympathetic nerve activity (MSNA) were continuously recorded while supine and during 75° head-up tilt (HUT). Cardiac vagal modulation (high frequency power,HFRR), sinoatrial node sympatho-vagal interaction (low-to high-frequency ratio,LF/HF), sympathetic vasomotor control (LFSAP) and arterial baroreflex sensitivity (αLF) were assessed by spectral analysis. Baroreflex sensitivity was also evaluated by spontaneous sequences (BRS) technique. RESULTS: At tVNS, MSNA decreased in both positions. tVNS increased HFRR and decreased LF/HF in supine. During HUT, αLF increased, HFRR increased, and HR decreased compared to Pre-tVNS. Total symptom score declined in both positions, with improvements in multiple mVOSS domains during tilt. At Post-tVNS, HFRR and BRS increased in both positions. During HUT, αLF increased, HR and LFSAP decreased. MSNA returned to Pre-tVNS in both positions. Total symptom score showed sustained improvement. CONCLUSIONS: Fourteen-day tVNS enhanced cardiovagal modulation, reduced sympathetic activity, and improved orthostatic symptoms in Hyper-POTS patients. Additionally, some benefits persisted beyond the stimulation period. Thus, tVNS could potentially be used as an additional therapeutic tool in Hyper-POTS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 42 - Pieve Emanuele, Milan, Italy; Humanitas Clinical and Research Center- IRCCS, Via Alessandro Manzoni, 56 Rozzano, Italy.
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 42 - Pieve Emanuele, Milan, Italy; Humanitas Clinical and Research Center- IRCCS, Via Alessandro Manzoni, 56 Rozzano, Italy; Autonomic D…
- Humanitas Clinical and Research Center- IRCCS, Via Alessandro Manzoni, 56 Rozzano, Italy.
- Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Department of Internal Medicine, General Medicine Unit, IRCCS Ca' Granda Foundation, Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Biomedical Sciences for Health, University of Milan, Milan, Italy; Department of Cardiothoracic Vascular and Intensive Care, IRCCS Policlinico S. Donato Milanese, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 42 - Pieve Emanuele, Milan, Italy; Department of Kinesiology, Universidad Católica del Maule, Talca, Chile.
Förderung
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Shiffer, D., Rigo, S., Minonzio, M., Yarsuvat, D. T., Tobaldini, E., Furlan, L., Montano, N., Cairo, B., Porta, A., Zamunér, A. R., Bonovas, S., Urechie, V., Biaggioni, I., Diedrich, A., & Furlan, R. (2026). Short and long term effects of a two-week transcutaneous vagus nerve stimulation in hyperadrenergic postural orthostatic tachycardia syndrome: a proof-of-concept trial. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2025.106529
Vancouver
Shiffer D, Rigo S, Minonzio M, Yarsuvat DT, Tobaldini E, Furlan L, et al. Short and long term effects of a two-week transcutaneous vagus nerve stimulation in hyperadrenergic postural orthostatic tachycardia syndrome: a proof-of-concept trial. European Journal of Internal Medicine. 2026. doi:10.1016/j.ejim.2025.106529
BibTeX
@article{Shiffer2026,
author = {Shiffer, Dana and Rigo, Stefano and Minonzio, Maura and Yarsuvat, Deniz Timothy and Tobaldini, Eleonora and Furlan, Ludovico and Montano, Nicola and Cairo, Beatrice and Porta, Alberto and Zamunér, Antonio Roberto and Bonovas, Stefanos and Urechie, Vasile and Biaggioni, Italo and Diedrich, André and Furlan, Raffaello},
title = {Short and long term effects of a two-week transcutaneous vagus nerve stimulation in hyperadrenergic postural orthostatic tachycardia syndrome: a proof-of-concept trial},
journal = {European Journal of Internal Medicine},
year = {2026},
doi = {10.1016/j.ejim.2025.106529}
}
EUVIMED